pubmed-article:19038547 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19038547 | lifeskim:mentions | umls-concept:C1579360 | lld:lifeskim |
pubmed-article:19038547 | lifeskim:mentions | umls-concept:C0599682 | lld:lifeskim |
pubmed-article:19038547 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:19038547 | pubmed:dateCreated | 2008-12-26 | lld:pubmed |
pubmed-article:19038547 | pubmed:abstractText | A series of enantiomerically pure 1-naphthyl and 4-indolyl arylalkylamines were prepared and evaluated for their binding affinities to the monoamine transporters. The two series of enantiomers displayed considerable differences in binding selectivity between the monoamine transporters, leading to the design of (S)-4-(3,4-dichlorophenyl)-4-(1H-indol-4-yl)-N-methylbutan-1-amine as a potent inhibitor for the dopamine and serotonin transporters. | lld:pubmed |
pubmed-article:19038547 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:language | eng | lld:pubmed |
pubmed-article:19038547 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19038547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19038547 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19038547 | pubmed:month | Jan | lld:pubmed |
pubmed-article:19038547 | pubmed:issn | 1464-3405 | lld:pubmed |
pubmed-article:19038547 | pubmed:author | pubmed-author:ChildersSteve... | lld:pubmed |
pubmed-article:19038547 | pubmed:author | pubmed-author:DaviesHuw M... | lld:pubmed |
pubmed-article:19038547 | pubmed:author | pubmed-author:SextonTammyT | lld:pubmed |
pubmed-article:19038547 | pubmed:author | pubmed-author:ManningJames... | lld:pubmed |
pubmed-article:19038547 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19038547 | pubmed:day | 1 | lld:pubmed |
pubmed-article:19038547 | pubmed:volume | 19 | lld:pubmed |
pubmed-article:19038547 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19038547 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19038547 | pubmed:pagination | 58-61 | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:meshHeading | pubmed-meshheading:19038547... | lld:pubmed |
pubmed-article:19038547 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19038547 | pubmed:articleTitle | 1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors. | lld:pubmed |
pubmed-article:19038547 | pubmed:affiliation | Department of Chemistry, University at Buffalo, The State University of New York, Buffalo, NY 14260-3000, USA. | lld:pubmed |
pubmed-article:19038547 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19038547 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19038547 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19038547 | lld:pubmed |